Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia

Journal of the Neurological Sciences

Volumn 161, Issue 1, 1998, Pages 47-56

  Terwel, Dick ^a   Bothmer, John ^a   Wolf, Ernst ^a   Meng, Fanping ^a   Jolles, Jellemer ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alzheimer's disease; Aminopeptidase; Antemortem hypoxia; Oxidative stress; PI kinase; Prolyl endopeptidase

Indexed keywords

2 OXOGLUTARIC ACID; AMINOPEPTIDASE; BETA GLUCURONIDASE; BRAIN ENZYME; CHOLINE ACETYLTRANSFERASE; LACTIC ACID; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PHOSPHATIDYLINOSITOL KINASE; PROLYL ENDOPEPTIDASE;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HYPOXIA; BRAIN METABOLISM; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROCHEMISTRY; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ANOXIA; BRAIN; CADAVER; FEMALE; HUMANS; LACTIC ACID; MALE; NERVE TISSUE PROTEINS; TIME FACTORS;

EID: 0032569826     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00240-8     Document Type: Article

References (51)

1. Andorn AC, Britton RS, Bacon BR Evidence that lipid peroxidation and total iron are increased in Alzheimer's brain. Neurobiol Aging. 11:1990;316.
2. Behl C, Davis JB, Lesley R, Schubert D Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
3. Bowen D.M., White P., Spillane J.A., Goodhardt M.J., Curzon G., Iwangoff P., Meier-Ruge W., Davidson A.N. Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet. 311:1979;11-14.
4. Brown GG, Garcia JH, Gdowski JW, Levine SR, Helpern JA Altered energy metabolism in demented patients with multiple subcortical ischemic lesions. Arch Neurol. 50:1993;384-388.
5. Cataldo AM, Paskevich PA, Kominami E, Nixon RA Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci USA. 88:1991;10998-11002.
6. Cross AJ, Crow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE Reduced dopamine-β-hydroxylase activity in Alzheimer's disease. Br Med J. 282:1981;93-94.
7. Cross AJ, Crow TJ, Dawson JM, Ferrier IN, Johnson JA, Peters TJ, Reynolds GP Subcellular pathology of human neurodegenerative disorders: Alzheimer-type dementia and Huntington's disease. J Neurochem. 47:1986;882-889.
8. Davies P Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res. 171:1979;319-327.
9. Fishman WH. β-Glucuronidase. In: Bergmeyer HU, editor. Methoden der enzymatische Analyse. Weinheim: Verlag Chemie, 1974:964-79.
10. Fonnum F A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem. 24:1975;407-409.
11. Gibson GE, Sheu K-F, Blass JP, Baker A, Carlson KC, Harding B, Perrino P Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol. 45:1988;836-840.
12. Good PF, Werner P, Hsu A, Olanow CW, Perl DP Evidence for neuronal oxidative damage in Alzheimer's disease. Am J Pathol. 149:1996;21-28.
13. Kingsbury AE, Foster OJF, Nisbet AP, Cairns N, Bray L, Eve DJ, Lees AJ, Marsden D Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol Brain Res. 28:1995;311-318.
14. Gutmann I, Wahlefeld AW. L-(+)-Lactat. Bestimmung mit Lactat-Dehydrogenase und NAD. In: Bergmeyer HU, editor. Methoden der enzymatische Analyse. Weinheim: Verlag Chemie, 1974:1510-4.
15. Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm. 61:1985;253-264.
16. Jolles J, Zwiers H, Dekker A, Wirtz KWA, Gispen WH ACTH1-24 affects protein phosphorylation and polyphosphoinositide metabolism in the rat brain. Biochem J. 194:1981;283-291.
17. Jolles J, Bothmer J, Markerink M, Ravid R Phosphatidylinositol kinase is reduced in Alzheimer's disease. J Neurochem. 58:1992;2326-2329.
18. Jolles J, Bothmer J, Markerink M, Ravid R Reduced PI kinase activity in Alzheimer's disease: effects of age and onset. Dementia. 4:1993;81-86.
19. Karkela J, Pasanen M, Kaukinen S, Morsky P, Harmoinen A Evaluation of hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate. Crit Care Med. 20:1992;378-386.
20. Lai JCK, Cooper AJL Brain α-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem. 47:1986;1376-1386.
21. Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA Transferrin and iron in normal, Alzheimer's disease and Parkinson's disease brain regions. J Neurochem. 65:1995;710-716.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
23. Maker HS, Weiss C, Weissbarth S, Silides DJ. The perimortem variation of glutamate decarboxylase and creatine kinase in human brain. In: Abstracts of the 8th meeting of the International Society of Neurochemistry, 1981:340.
24. Mantle D, Lauffart B, Perry EK, Perry RH Comparison of major cortical aminopeptidase activity in normal brain and brain from patients with Alzheimer's disease. J Neurol Sci. 89:1989;227-234.
25. Mantle D, Falkous G, Ishiura S, Blanchard PJ, Perry EK Comparison of proline endopeptidase activity in brain from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. Clin Chim Acta. 249:1996;129-139.
26. McGeer PL, McGeer EG, Akiyama H, Harrop R. Regional deficits in conical metabolism in PET-scanned Alzheimer cases correlate with postmortem indices of gliosis, and not with choline acetyltransferase. In: Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM, editors. Alzheimer's disease: basic mechanisms, diagnosis and therapeutics. Chichester: Wiley, 1990:59-68.
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
28. Milner TA, Pickel VM, Park DH, Joh TH, Reis DJ Light microscopic immunocytochemical localization of pyruvate dehydrogenase complex in rat brain: topographical distribution and relation to cholinergic and catecholaminergic nuclei. J Neurosci. 7:1987;3171-3190.
29. Moritz A, De Graan PNE, Ekhart PF, Gispen WH, Wirtz KWA Purification of a phosphatidylinositol 4-phosphate kinase from bovine brain membranes. J Neurochem. 54:1990;351-354.
30. Palmer AM, Burns MA Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res. 645:1994;338-342.
31. Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci. 34:1977;227-234.
32. Perry EK, Perry RH. The cholinergic system in Alzheimer's disease. In: Roberts PJ, editor. Biochemistry of dementia. Chichester: Wiley, 1980:135-83.
33. Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase. Neurosci Lett. 18:1980;105-110.
34. Phillis JW A 'radical' view of cerebral ischemic injury. Prog Neurobiol. 44:1994;1-8.
35. Reinikainen KJ, Paljarvil L, Huuskonen M, Soininen H, Laakso M, Riekkinen PJ A postmortem study of noradrenergic, serotonergic, and GABAergic neurons in Alzheimer's disease. J Neurol Sci. 84:1988;101-116.
36. Reisberg B, Ferris SH, De Leon MJ, Cook T Alzheimer's disease: a report of progress. Am J Psychol. 139:1982;1136-1139.
37. Rokutan K, Kawai K, Arada K Inactivation of 2-oxoglutarate dehydrogenase in rat liver mitochondria by its substrate and t-butylhydroperoxide. J Biochem (Tokyo). 101:1987;415-422.
38. Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J. 288:1984;961-964.
39. Sarath G, De La Motte RS, Wagner FM. Protease assay methods. In: Beynon RJ, Bond JS, editors. Proteolytic enzymes: a practical approach. Oxford: Oxford University Press, 1990:25-55.
40. Schoonen WG, Wanamarta AH, van der Klei-van Moorsel JM, Jakobs C, Joenje H Respiratory failure and stimulation of glycolysis in Chinese hamster ovary cells exposed to normobaric hyperoxia. J Biol Chem. 265:1990;1118-1124.
41. Siesjö BK. A new perspective on ischemic brain damage. In: Kogure K, Hossmann K-A, Siesjö BK, editors. Neurobiology of ischemic brain damage. Amsterdam: Elsevier, 1993:1-9.
42. Siesjö BK, Katsura K-i, Mellergård P, Ekholm A, Lundgren J, Smith M-L. Acidosis-related brain damage. In: Kogure K, Hossmann K-A, Siesjö BK, editors. Neurobiology of ischemic brain damage. Amsterdam: Elsevier, 1993:23-48.
43. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR Excess protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc Natl Acad Sci USA. 88:1991;10540-10543.
44. Smith MA, Perry G, Richy PL, Sayre LM, Anderson VE, Beal MF, Kowall N Oxidative damage in Alzheimer's. Nature. 382:1996;120-121.
45. Terwel D, Markerink M, Jolles J Peptidases are affected differently in neocortical regions of brains from patients with Alzheimer's disease. Dementia. 3:1992;108-113.
46. Tsukahara T, Ishiura S, Sugita H Regulation of prolyl endopeptidase activity by intracellular redox state. J Biol Chem. 265:1990;21448-21453.
47. Van Dongen CJ, Kok JW, Schrama LH, Oestreicher AB, Gispen WH Immunochemical characterization of phosphatidylinositol 4-phosphate kinase from rat brain. Biochem J. 233:1986;859-864.
48. Welsh FA, Sakamoto T, McKee AE, Sims RE Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain. J Neurochem. 49:1987;846-851.
49. Yates CM, Butterworth J, Tennant MC, Gordon A Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem. 55:1990;1624-1630.
50. Zanozdra M, Kmelevs'kii IuV Activity of enzymes of tricarboxylic and pentose-phosphate cycles in dog brain with myocardial infarction. Ukr Biokhim Zh. 49:1977;51-54.
51. Butterworth J., Tennant M.C. Postmortem human brain pH and lactate in sudden infant death syndrome. J Neurochem. 53:1989;1494-1499.